TREA

87317376 - IT-DIAB

Follow

Information

  • Trademark
  • 87317376
  • Serial Number
    87317376
  • Registration Number
    5410374
  • Filing Date
    January 30, 2017
    8 years ago
  • Registration Date
    February 27, 2018
    7 years ago
  • Transaction Date
    October 15, 2024
    6 months ago
  • Status Date
    September 09, 2024
    7 months ago
  • Published for Opposition Date
    December 12, 2017
    7 years ago
  • Location Date
    February 27, 2018
    7 years ago
  • Status Code
    710
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    MURRAY, GEORGE
  • Attorney Docket Number
    04774.T630US
    Attorney Name
    Brooks R. Bruneau
    Law Office Assigned Location Code
    N30
  • Owners
Information
Mark Drawing Code
4
Mark Identification
IT-DIAB
Case File Statements
  • GS0091: Electronic databases and computer programs for retrieving, compiling, integrating and sending data relating to research on type II diabetes, prediabetes and their associated acute or chronic complications in particular experimental data concerning the targets, biomarkers, cellular models and animal testing models which are being used or developed; Electronic databases and computer programs for retrieving, compiling, integrating and sending data relating to methods for the preventive or curative treatment of type II diabetes, of prediabetes and their acute or chronic complications; Electronic databases and computer programs for retrieving, compiling, integrating and sending medical data relating to the condition of patients monitored for the preventive or curative treatment of type II diabetes, of prediabetes and their acute or chronic complications
  • GS0051: Pharmaceutical preparations and substances, preparations for medical use, for the preventive and curative treatment of type II diabetes, of prediabetes and their acute or chronic complications; Preparations, products and devices for medical use, in particular, diagnostic biomarkers and cellular models for the in vivo, ex vivo or in vitro diagnosis of type II diabetes, of prediabetes and their associated acute or chronic complications; Preparations, products and devices, in particular, diagnostic biomarkers and cellular models for the medical follow-up of patients at risk or of patients suffering from type II diabetes, prediabetes and their associated acute or chronic complications; Preparations, products and devices in particular diagnostic biomarkers and cellular models for the selection and assessment of drugs and their compounds for their preventive and curative properties towards type II diabetes, prediabetes and their associated acute or chronic complications
  • GS0011: Active principles, namely, active chemical ingredients used in manufacturing pharmaceuticals for treating type II diabetes, prediabetes and their acute or chronic complications
  • GS0421: Scientific research in the field of prevention, diagnosis, screening, preventive or curative treatment of type II diabetes, of prediabetes and their acute or chronic complications; Scientific research, in particular clinical research on the assessment of the effects of drugs and their compounds having preventive or curative properties of type II diabetes, prediabetes and their acute or chronic complications; Development and validation of tests for the diagnosis and medical follow-up of patients at risk or of patients suffering from type II diabetes, prediabetes and their associated acute or chronic complications; Development and validation of biological tests in vitro, ex vivo and in vivo for sorting and selecting compounds, products and substances intended for the preventive or curative treatment of type II diabetes, prediabetes and their associated acute or chronic complications
Case File Event Statements
  • 2/2/2017 - 8 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 2/2/2017 - 8 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 4/25/2017 - 8 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/25/2017 - 8 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/25/2017 - 8 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/25/2017 - 8 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 10/20/2017 - 7 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/20/2017 - 7 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/21/2017 - 7 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/31/2017 - 7 years ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/22/2017 - 7 years ago
    11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/12/2017 - 7 years ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/12/2017 - 7 years ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/27/2018 - 7 years ago
    14 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 2/27/2023 - 2 years ago
    15 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 9/9/2024 - 7 months ago
    16 - CANCELLED SEC. 8 (6-YR) Type: C8..